Alto Neuroscience Inc

ANRO has decisively broken below short-term EMAs and a prior support cluster on strong volume, confirming continued medium-term bearish control. Short-term momentum is down with price trading below the 9- and 20-day EMAs and RSI trending lower, favoring selling into any rebounds near the broken EMA and support zone. The longer-term uptrend remains intact with price above the 200-day SMA, limiting bearish conviction and signaling that rallies may provide optimal entry points for further selling.

• ↑Stock gained 9.2% over past two weeks, signaling strong momentum factors.
• ↑“Moderate Buy” consensus with $36.63 target implies 25.8% upside.
• ↓EPS expected to fall from ($3.14) to ($3.56), indicating financial strain.